Board Meeting Intimation for Results & Closure of Trading Window
Jagsonpal Pharmaceuticals Ltd has informed BSE regarding "Board Meeting Intimation for Results & Closure of Trading Window".03-02-2017
Board Meeting Intimation for Results & Closure of Trading Window
Jagsonpal Pharmaceuticals Ltd has informed BSE regarding "Board Meeting Intimation for Results & Closure of Trading Window".Shareholding for the Period Ended December 31, 2016
Jagsonpal Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click hereStatement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Jagsonpal Pharmaceuticals Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Standalone Financial Results, Limited Review Report for September 30, 2016
Jagsonpal Pharmaceuticals Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Standalone Limited Review for the period ended September 30, 2016Board Meeting Intimation for Results
Jagsonpal Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 11, 2016, inter alia, to consider and approve the Un-audited Financial Results (provisional) of the Company for the second quarter/ and half year ended September 30, 2016.Shareholding for the Period Ended September 30, 2016
Jagsonpal Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click hereStatement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Jagsonpal Pharmaceuticals Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Jagsonpal Pharmaceuticals Ltd has informed BSE regarding the details of Voting results at the Annual General Meeting (AGM) of the Company held on September 30, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report.Outcome of AGM
Jagsonpal Pharmaceuticals Ltd has informed BSE that the Proceedings of the 37th Annual General Meeting (AGM) of the Company was held on September 30, 2016.Fixes Book Closure for Dividend & A G M
Jagsonpal Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2016 to September 30, 2016 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company.